Titre : Artériosclérose intracrânienne

Artériosclérose intracrânienne : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multicenter Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Artériosclérose intracrânienne : Questions médicales les plus fréquentes", "headline": "Artériosclérose intracrânienne : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Artériosclérose intracrânienne : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-30", "dateModified": "2025-04-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Artériosclérose intracrânienne" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Artériopathies intracrâniennes", "url": "https://questionsmedicales.fr/mesh/D020765", "about": { "@type": "MedicalCondition", "name": "Artériopathies intracrâniennes", "code": { "@type": "MedicalCode", "code": "D020765", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253.560" } } }, "about": { "@type": "MedicalCondition", "name": "Artériosclérose intracrânienne", "alternateName": "Intracranial Arteriosclerosis", "code": { "@type": "MedicalCode", "code": "D002537", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Daniel Bos", "url": "https://questionsmedicales.fr/author/Daniel%20Bos", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "Meike W Vernooij", "url": "https://questionsmedicales.fr/author/Meike%20W%20Vernooij", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "M Arfan Ikram", "url": "https://questionsmedicales.fr/author/M%20Arfan%20Ikram", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "Tim C van den Beukel", "url": "https://questionsmedicales.fr/author/Tim%20C%20van%20den%20Beukel", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } }, { "@type": "Person", "name": "Frank J Wolters", "url": "https://questionsmedicales.fr/author/Frank%20J%20Wolters", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology, Erasmus Medical Center, Rotterdam, CA, The Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.", "datePublished": "2024-03-07", "url": "https://questionsmedicales.fr/article/38451463", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40120-024-00591-z" } }, { "@type": "ScholarlyArticle", "name": "Carbon dioxide gas-induced pneumothorax versus one-lung ventilation in minimally invasive esophagectomy: a multicenter propensity score matching cohort study.", "datePublished": "2024-03-01", "url": "https://questionsmedicales.fr/article/38051934", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/JS9.0000000000000968" } }, { "@type": "ScholarlyArticle", "name": "Pooled Minimal Clinically Important Differences of the Mini-Balance Evaluation Systems Test in Patients with Early Subacute Stroke: A Multicenter Prospective Observational Study.", "datePublished": "2024-02-14", "url": "https://questionsmedicales.fr/article/38365440", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/ptj/pzae017" } }, { "@type": "ScholarlyArticle", "name": "A Multicenter Cohort Study on 301 Tissue-Level Implants: Cumulative Implant Survival Rate and Marginal Bone Level Change Up to 4.5 Years.", "datePublished": "2024-01-24", "url": "https://questionsmedicales.fr/article/38265484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.11607/jomi.10141" } }, { "@type": "ScholarlyArticle", "name": "Systematic reduction of gray matter volume in anorexia nervosa, but relative enlargement with clinical symptoms in the prefrontal and posterior insular cortices: a multicenter neuroimaging study.", "datePublished": "2024-01-22", "url": "https://questionsmedicales.fr/article/38246936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41380-023-02378-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Angiopathies intracrâniennes", "item": "https://questionsmedicales.fr/mesh/D002561" }, { "@type": "ListItem", "position": 5, "name": "Artériopathies intracrâniennes", "item": "https://questionsmedicales.fr/mesh/D020765" }, { "@type": "ListItem", "position": 6, "name": "Artériosclérose intracrânienne", "item": "https://questionsmedicales.fr/mesh/D002537" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Artériosclérose intracrânienne - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Artériosclérose intracrânienne", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-03", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Artériosclérose intracrânienne", "description": "Comment diagnostiquer l'artériosclérose intracrânienne ?\nQuels tests sont utilisés pour évaluer la circulation cérébrale ?\nQuels signes cliniques indiquent une artériosclérose intracrânienne ?\nL'évaluation neurologique est-elle nécessaire ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Artériosclérose intracrânienne", "description": "Quels sont les symptômes courants de l'artériosclérose intracrânienne ?\nL'artériosclérose intracrânienne cause-t-elle des AVC ?\nPeut-on avoir des symptômes sans douleur ?\nLes troubles cognitifs sont-ils fréquents ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Artériosclérose intracrânienne", "description": "Comment prévenir l'artériosclérose intracrânienne ?\nLe contrôle de la pression artérielle est-il important ?\nLe tabagisme influence-t-il le risque ?\nL'exercice régulier aide-t-il à prévenir la maladie ?\nLes examens médicaux réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Artériosclérose intracrânienne", "description": "Quels traitements sont disponibles pour l'artériosclérose intracrânienne ?\nLes anticoagulants sont-ils utilisés ?\nLa rééducation est-elle nécessaire après un AVC ?\nLes changements de mode de vie sont-ils recommandés ?\nDes interventions chirurgicales sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Artériosclérose intracrânienne", "description": "Quelles complications peuvent survenir ?\nL'artériosclérose intracrânienne peut-elle entraîner des crises ?\nLes troubles de la mémoire sont-ils une complication ?\nPeut-on avoir des troubles de l'équilibre ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Artériosclérose intracrânienne", "description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLe cholestérol élevé influence-t-il le risque ?\nLe stress a-t-il un impact sur le risque ?\nLes antécédents familiaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D002537?mesh_terms=Multicenter+Studies+as+Topic&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'artériosclérose intracrânienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'imagerie cérébrale, comme l'IRM ou le scanner." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la circulation cérébrale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'angiographie cérébrale et l'échographie Doppler sont utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une artériosclérose intracrânienne ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des maux de tête persistants et des troubles neurologiques peuvent indiquer la maladie." } }, { "@type": "Question", "name": "L'évaluation neurologique est-elle nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une évaluation neurologique complète est essentielle pour le diagnostic." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour cette condition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'artériosclérose intracrânienne ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles de la vision." } }, { "@type": "Question", "name": "L'artériosclérose intracrânienne cause-t-elle des AVC ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut augmenter le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent présenter des symptômes neurologiques sans douleur." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils fréquents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de la réduction du flux sanguin." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de la maladie." } }, { "@type": "Question", "name": "Comment prévenir l'artériosclérose intracrânienne ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un mode de vie sain, incluant une alimentation équilibrée et de l'exercice." } }, { "@type": "Question", "name": "Le contrôle de la pression artérielle est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir une pression artérielle normale est crucial pour prévenir la maladie." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque d'artériosclérose intracrânienne." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir la maladie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier contribue à la santé cardiovasculaire et à la prévention." } }, { "@type": "Question", "name": "Les examens médicaux réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers aident à détecter les problèmes précocement." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'artériosclérose intracrânienne ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments pour contrôler la pression artérielle et des interventions chirurgicales." } }, { "@type": "Question", "name": "Les anticoagulants sont-ils utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent être prescrits pour prévenir les caillots sanguins." } }, { "@type": "Question", "name": "La rééducation est-elle nécessaire après un AVC ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la rééducation est souvent nécessaire pour récupérer des fonctions perdues." } }, { "@type": "Question", "name": "Les changements de mode de vie sont-ils recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements comme une alimentation saine et l'exercice sont recommandés." } }, { "@type": "Question", "name": "Des interventions chirurgicales sont-elles possibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des interventions comme le pontage ou l'angioplastie peuvent être envisagées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les AVC, les démences et les troubles cognitifs." } }, { "@type": "Question", "name": "L'artériosclérose intracrânienne peut-elle entraîner des crises ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut augmenter le risque de crises épileptiques chez certains patients." } }, { "@type": "Question", "name": "Les troubles de la mémoire sont-ils une complication ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la mémoire peuvent survenir en raison de la réduction du flux sanguin." } }, { "@type": "Question", "name": "Peut-on avoir des troubles de l'équilibre ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de l'équilibre peuvent être une complication de cette maladie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'artériosclérose augmente avec l'âge." } }, { "@type": "Question", "name": "Le cholestérol élevé influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un taux de cholestérol élevé est un facteur de risque significatif." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'augmentation du risque." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'artériosclérose augmentent le risque." } } ] } ] }

Sources (10000 au total)

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.

Long-term (1-year) fremanezumab treatment proved to be effective, safe, and well tolerated in individuals with migraine and < 2 medication clusters in a randomized controlled trial (RCT). We aimed to ... A 48-week, prospective, multicenter (n = 26), cohort study assessed fremanezumab's effectiveness, safety, and tolerability in consecutive adults with HFEM or CM with > 3 treatment failures. Primary en... Of 533 participants who had received ≥ 1 fremanezumab dose, 130 were treated for ≥ 48 weeks and considered for effectiveness analysis. No participant missed any treatment dosage every other consecutiv... fremanezumab significantly (p < 0.001) reduced both MMD (- 6.4) in HFEM and MHD (- 14.5) in CM. Secondary endpoints: a significant reduction (p < 0.001) was observed in monthly analgesic medications (... This RWE study documents that long-term fremanezumab treatment is highly effective and remarkably well tolerated in subjects with HFEM or CM with multiple (> 3) therapeutic failures, even in the prese...

Carbon dioxide gas-induced pneumothorax versus one-lung ventilation in minimally invasive esophagectomy: a multicenter propensity score matching cohort study.

Carbon dioxide gas-induced pneumoperitoneum might be the reason for the shorter postoperative survival of patients with malignant tumors. Whether CO 2 gas-induced pneumothorax has unfavorable impacts ... Between 2010 and 2016, a total of 998 patients with squamous cell carcinoma of the esophagus who received video-assisted surgery were registered from three large-volume medical centers. The overall su... A total of 422 and 576 minimally invasive esophagectomies with intraoperative one-lung ventilation and CO 2 -induced pneumothorax were enrolled, respectively. The 5-year OS and DFS were similar betwee... The results of this study suggested that the use of intraoperative one-lung ventilation and CO 2 -induced pneumothorax have similar oncological outcomes; therefore, the two methods are both viable opt...

Pooled Minimal Clinically Important Differences of the Mini-Balance Evaluation Systems Test in Patients with Early Subacute Stroke: A Multicenter Prospective Observational Study.

Balance problems are common in patients with stroke, and the Mini-Balance Evaluation Systems Test (Mini-BESTest) is a reliable and valid assessment tool for measuring balance function. Determining the... In this prospective multicenter study, 53 patients with early subacute stroke undergoing rehabilitation in inpatient units were included. The mean age of the patients was 72.6 (SD = 12.2) years. The M... The MCID values for the Mini-BESTest obtained through the 4 methods ranged from 3.2 to 4.5 points when using the physical therapist's GRC score as the anchor but could not be calculated using the part... The Mini-BESTest MCID obtained in this study is valuable for identifying improvements in balance function among patients with early subacute stroke.... Determination of the MCID is valuable for evaluating treatment effectiveness. The study findings provide clinicians with practical values that can assist in interpreting Mini-BESTest results and asses...

A Multicenter Cohort Study on 301 Tissue-Level Implants: Cumulative Implant Survival Rate and Marginal Bone Level Change Up to 4.5 Years.

The aim of this multi-center cohort study in private practices was to retrospectively determine the Cumulative Survival Rate (CSR) and the marginal bone level change (ΔMBL) around novel hybrid design ... Implant CSRs were analyzed at implant and patient level using Kaplan-Meier. ΔMBL was measured by comparison of peri-apical radiographs available both at loading and at a follow-up visit with an improv... A total of 301 TL implants in 69 patients with an average age of 62.6 ± 11.7 years (36-87 years) at the time of implantation were considered for the analysis. All 301 implants were successfully restor... The high cumulative survival rates and stable peri-implant marginal bone levels support the use of recent TL implants, with a hybrid design inherited from bone level implant-abutment connection, as a ...

Von Willebrand Factor Antigen Levels Predict Poor Outcomes in Patients With Stroke and Cancer: Findings From the Multicenter, Prospective, Observational SCAN Study.

Patients with acute ischemic stroke and active cancer have more severe neurological symptoms, elevated risks of stroke recurrence, and death compared with the general population. We examined whether v... Using data from 90 patients with acute ischemic stroke and active cancer who were registered in the SCAN (Ischemic Stroke in Patients With Cancer and Neoplasia) study, a prospective multicenter, obser... Elevated vWF antigen levels were associated with adverse outcomes in patients with cancer-associated stroke and may represent a useful biomarker to guide future therapeutic interventions....

Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study.

Paclitaxel liposome (Lipusu) is known to be effective in non-small cell lung cancer (NSCLC) as first-line treatment. This study aimed to evaluate the effectiveness and safety of paclitaxel liposome ba... In this multicenter, retrospective, real-world study, patients with advanced NSCLC who were administered paclitaxel liposome based chemotherapy plus PD-1/PD-L1 inhibitor in three centers (Peking Unive... A total of 49 patients were included, with 33 (67.3%) receiving paclitaxel liposome based chemotherapy plus PD-1/PD-L1 inhibitor as first-line treatment. There were 34 patients (69.4%) diagnosed with ... Paclitaxel liposome based chemotherapy plus PD-1/PD-L1 inhibitor prolonged the PFS in advanced NSCLC with acceptable safety, which was worthy of clinical application....

Multimodal home-based rehabilitation intervention after discharge from inpatient geriatric rehabilitation (GeRas): study protocol for a multicenter randomized controlled trial.

Geriatric rehabilitation aims to maintain the functional reserves of older adults in order to optimize social participation and prevent disability. After discharge from inpatient geriatric rehabilitat... The study is a multicenter, three-arm, randomized controlled trial with a three-month intervention period. Two hundred and seventy community-dwelling older people receiving inpatient geriatric rehabil... The GeRas program is designed to improve the collaboration between health-care providers in the transition from inpatient geriatric rehabilitation to outpatient settings. Compared to usual care, it is... German Clinical Trials Register (DRKS00029559). Registered on October 05, 2022....

A comparative analysis of Postpartum Hemorrhage incidence and influencing factors between nulliparous and multiparous women in Hunan Province, China: A multicenter retrospective cohort study.

Postpartum hemorrhage (PPH) is a common cause of maternal death worldwide, but data on PPH incidence and influencing factors for nulliparous and multiparous women is scarce. So, the study aimed to ass... A multicenter retrospective cohort study was conducted among women who gave birth at ≥ 28 weeks of gestation in Hunan Province, China, from January 2017 to December 2018. Logistic regression assessed ... A total of 144,845 postpartum women were included in the study. The incidence of PPH (blood loss ≥ 500 ml) was 2.1 % and 1.7 % for nulliparous and multiparous women, respectively. Among the nulliparou... PPH incidence is higher among nulliparous women than among multiparous women, but influencing factors vary relatively by parity. The study findings provide new insights into the use of different appro...